Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2013-12-31, filed 2014-02-14, with 56 holding rows worth $810,358,000.

Accession
0001425738-14-000001
Filed
2014-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2013

A holdings report, 56 entries on the cover page, a total value of $810,358,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $810,358,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Gilead Sciences,Inc.375558103COM647,287$48,644,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM572,270$34,491,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock367,640$34,260,000thousands by filing date
CELGENE CORP151020104COM183,018$30,923,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR511,120$30,345,000thousands by filing date
ACTAVIS PLCG0083B108SHS172,240$28,936,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK230,673$23,882,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock182,561$23,105,000thousands by filing date
INCYTE CORP COM45337C102Stock448,998$22,733,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock4,460,688$22,348,000thousands by filing date
ALLERGAN INC018490102COM199,727$22,186,000thousands by filing date
GLOBUS MED INC CL A379577208Stock1,086,637$21,928,000thousands by filing date
Bristol-Myers Squibb Company110122108COM400,870$21,306,000thousands by filing date
HEARTWARE INTL INC422368100COM222,023$20,861,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM557,761$20,777,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM8,648,087$20,323,000thousands by filing date
HCA Healthcare Inc40412C101COM419,100$19,995,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock461,402$19,434,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS946,457$18,342,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM265,949$18,159,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK625,133$18,123,000thousands by filing date
NUVASIVE INC670704105COM550,914$17,811,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock205,300$16,683,000thousands by filing date
Pfizer Inc.717081103COM536,000$16,418,000thousands by filing date
ACCURAY INC DEL004397105COM1,744,811$15,197,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS359,977$14,953,000thousands by filing date
MERCK & CO INC58933Y905CALL282,500$14,139,000thousands by filing datecall
FOREST LABS INC345838106COM228,100$13,693,000thousands by filing date
INSULET CORP COM45784P101Stock363,036$13,469,000thousands by filing date
CERUS CORP157085101COM2,055,574$13,258,000thousands by filing date
ST JUDE MED INC790849103COM213,164$13,206,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM754,660$13,010,000thousands by filing date
HEALTHWAYS INC422245100COM846,413$12,992,000thousands by filing date
CHIMERIX INC COM16934W106Stock746,405$11,278,000thousands by filing date
OPHTHOTECH CORP683745103COM316,521$10,239,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM397,951$9,634,000thousands by filing date
VCA ANTECH INC918194101COM306,200$9,602,000thousands by filing date
TORNIER NVN87237108COMMON STOCK-FO487,577$9,162,000thousands by filing date
ILLUMINA INC452327109COM81,674$9,035,000thousands by filing date
SIRONA DENTAL SYSTEMS INC82966C103COM124,425$8,735,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW3,988,200$7,857,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK690,770$6,908,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM286,057$6,199,000thousands by filing date
ENDOLOGIX INC29266S106COM315,733$5,506,000thousands by filing date
AMBIT BIOSCIENCES CORP02318X100COM545,985$5,263,000thousands by filing date
XOMA CORP DEL98419J107COM781,176$5,257,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK284,400$4,439,000thousands by filing date
Foundation Medicine Inc350465100COM110,092$2,622,000thousands by filing date
MODEL N INC607525102COM91,307$1,077,000thousands by filing date
MARKET VECTORS PHARM ETF T57060U217ETF6,500$345,000thousands by filing date
ISHARES TR464288828US HLTHCR PR ETF3,000$280,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock1,000$275,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock9,100$241,000thousands by filing date
DYAX CORP26746E103COM25,000$188,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW35,000$166,000thousands by filing date
Merck & Co.,Inc.58933Y105COM2,400$120,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001425738-14-000001this filing2014-02-14acceptance time not in the bulk data set